GLOBEIMMUNE INC: 10-Q/A filed 2014-09-05

Name: GLOBEIMMUNE INC: 10-Q/A filed 2014-09-05
Creator: GLOBEIMMUNE INC

What GLOBEIMMUNE INC reported in its quarterly report amendment filed 2014-09-05 (fiscal Q2 2014): 26 published measures, 64 facts as tagged in accession 0001564590-14-004013.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-Q/A (quarterly report amendment)
Filed: 2014-09-05
Fiscal period: fiscal Q2 2014
Accession: 0001564590-14-004013 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GLOBEIMMUNE INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-06-30	10,213,176	USD
At 2013-12-31	7,417,939	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-06-30	29,959,128	USD
At 2013-12-31	19,057,383	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-06-30	-214,303,450	USD
At 2013-12-31	-199,321,834	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-06-30	6,461,745	USD
At 2013-12-31	5,924,241	USD
At 2013-06-30	332,036	USD
At 2012-12-31	2,002,948	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-5,713,955	USD	91
2014-01-01 to 2014-06-30	-8,158,527	USD	181
2013-04-01 to 2013-06-30	1,080,708	USD	91
2013-01-01 to 2013-06-30	-470,864	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	-5,890,694	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	173,182	USD	181
2013-01-01 to 2013-06-30	12,233	USD	181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	1,731,018	USD	91
2014-01-01 to 2014-06-30	3,149,364	USD	181
2013-04-01 to 2013-06-30	4,222,197	USD	91
2013-01-01 to 2013-06-30	6,354,464	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-06-30	214,303,548	USD
At 2013-12-31	199,321,927	USD

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-1.25	USD/shares	91
2014-01-01 to 2014-06-30	-2.19	USD/shares	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-06-30	488,634	USD
At 2013-12-31	492,802	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	46,506	USD	181
2013-01-01 to 2013-06-30	109,752	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-06-30	9,624,542	USD
At 2013-12-31	6,825,137	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	2,227,167	USD	91
2014-01-01 to 2014-06-30	3,713,853	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-06-30	20,018,324	USD
At 2013-12-31	6,414,495	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2014-06-30	1,306,919	USD
At 2013-12-31	1,736,621	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	3,067,315	USD	91
2014-01-01 to 2014-06-30	5,690,592	USD	181
2013-04-01 to 2013-06-30	3,624,945	USD	91
2013-01-01 to 2013-06-30	7,795,427	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	2,140,207	USD	91
2014-01-01 to 2014-06-30	3,678,986	USD	181
2013-04-01 to 2013-06-30	2,695,229	USD	91
2013-01-01 to 2013-06-30	5,908,636	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-06-30	98,226	shares
At 2013-12-31	92,812	shares

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2014-06-30	100,000	USD
At 2013-12-31	100,000	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2014-06-30	231,278	USD
At 2013-12-31	223,029	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2014-06-30	1,054,893	USD
At 2013-12-31	920,962	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-9,151,511	USD	91
2014-01-01 to 2014-06-30	-15,033,635	USD	181
2013-04-01 to 2013-06-30	-2,140,577	USD	91
2013-01-01 to 2013-06-30	-6,913,434	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	855,693	USD	91
2014-01-01 to 2014-06-30	1,870,325	USD	181
2013-04-01 to 2013-06-30	713,602	USD	91
2013-01-01 to 2013-06-30	1,450,747	USD	181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	25,513	USD	181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	-429,702	USD	181
2013-01-01 to 2013-06-30	1,577,662	USD	181

Inspect the source

Entity: GLOBEIMMUNE INC / CIK 0001245104
Captured: 2026-09-23 02:49 UTC
SEC response SHA-256: 0591d730983e8b532bfe42077c31768b864368a8bdfb4c330a0da5803d43f904

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001245104.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))